[{"NetIncomeLoss_1_Q1_USD":-20958000.0,"RepaymentsOfLongTermDebt_1_Q1_USD":0.0,"CommitmentsAndContingencies_0_Q1_USD":null,"AccruedLiabilitiesCurrent_0_Q1_USD":22409000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q1_USD":369000.0,"InterestPaidNet_1_Q1_USD":0.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":5000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-17724000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":16399000.0,"PaymentsToAcquireInvestments_1_Q1_USD":21686000.0,"AccruedLiabilitiesCurrentAndNoncurrent_0_Q1_USD":22409000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":530000.0,"AssetsCurrent_0_Q1_USD":145416000.0,"LongTermDebtCurrent_0_Q1_USD":11660000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":0.0,"TreasuryStockShares_0_Q1_shares":1165000.0,"AvailableForSaleSecurities_0_Q1_USD":43709000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q1_USD":548000.0,"TreasuryStockValue_0_Q1_USD":7518000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":1162000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"RoyaltyIncomeNonoperating_1_Q1_USD":27000.0,"OperatingLeaseLiability_0_Q1_USD":2743000.0,"Liabilities_0_Q1_USD":40713000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":3248000.0,"EarningsPerShareBasic_1_Q1_USD":-0.15,"OtherNonoperatingIncomeExpense_1_Q1_USD":48000.0,"AccountsReceivableNetCurrent_0_Q1_USD":101000.0,"CommonStockValue_0_Q1_USD":145000.0,"Revenues_1_Q1_USD":27000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":-8418000.0,"TreasuryStockValueAcquiredCostMethod_1_Q1_USD":2675000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":37000.0,"CashAndCashEquivalentsPeriodIncreaseDecrease_1_Q1_USD":-28611000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":14272000.0,"RealizedInvestmentGainsLosses_1_Q1_USD":0.0,"OtherAssetsCurrent_0_Q1_USD":3954000.0,"IncreaseDecreaseInInventories_1_Q1_USD":0.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-20947000.0,"OtherAssetsNoncurrent_0_Q1_USD":3005000.0,"ShortTermLeaseCommitmentAmount_0_Q1_USD":1000000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":97652000.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_1_Q1_USD":4000000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":11000.0,"CommonStockSharesIssued_0_Q1_shares":145552000.0,"Assets_0_Q1_USD":193260000.0,"ShareBasedCompensation_1_Q1_USD":2851000.0,"DebtInstrumentFairValue_0_Q1_USD":12600000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":5851000.0,"Goodwill_0_Q1_USD":44543000.0,"LongTermDebtAndCapitalLeaseObligations_0_Q1_USD":1717000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":2851000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-25159000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":143379000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":644000.0,"LiabilitiesCurrent_0_Q1_USD":38995000.0,"AccountsPayableCurrent_0_Q1_USD":4926000.0,"InterestExpense_1_Q1_USD":167000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q1_USD":97652000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":1326000.0,"IncreaseDecreaseInOtherOperatingAssets_1_Q1_USD":74000.0,"AdditionalPaidInCapital_0_Q1_USD":1580891000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q1_USD":152547000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q1_shares":-109000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":296000.0,"InvestmentsFairValueDisclosure_0_Q1_USD":141361000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":-294000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-1420976000.0,"AmortizationOfFinancingCostsAndDiscounts_1_Q1_USD":14000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":2900000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.01,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":16947000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":505000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":543000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-1095000.0,"CommonStockSharesAuthorized_0_Q1_shares":225000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":0.0,"ResearchAndDevelopmentExpense_1_Q1_USD":12609000.0,"OperatingIncomeLoss_1_Q1_USD":-20839000.0,"PreferredStockValue_0_Q1_USD":0.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1_Q1_USD":5.03,"LiabilitiesAndStockholdersEquity_0_Q1_USD":193260000.0,"PreferredStockSharesAuthorized_0_Q1_shares":5000000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":-1026000.0,"OperatingExpenses_1_Q1_USD":20866000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":1718000.0,"StockholdersEquity_0_Q1_USD":152547000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":38000.0,"PaymentsForRepurchaseOfCommonStock_1_Q1_USD":2675000.0,"ShortTermInvestments_0_Q1_USD":43709000.0,"Ticker":"LXRX","CIK":"1062822","name":"LEXICON PHARMACEUTICALS, INC.","OfficialName":"Lexicon Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"332097683.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20210506"}]